Clinical Trial Update: A Trial of a Peptide-based Group A Streptococcal (GAS) Vaccine Candidate in Healthy Individuals. [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 clinical trial evaluating a peptide-based vaccine candidate for Group A Streptococcal infection in healthy v…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Group Streptococcal Infection

Drugs mentioned

• Peptide-based Group A Streptococcal vaccine candidate

Snippet

Sponsor: University of Alberta | Conditions: Group A Streptococcal Infection | Phase 1, Phase 2 | Status: COMPLETED